Fundraising FoxEntasis Therapeutics Holdings
Waltham, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Entasis Therapeutics Holdings
Sign up to see every warm intro you have to Entasis Therapeutics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Entasis Therapeutics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Entasis Therapeutics Holdings was founded in 2018 by Manoussos Perros.
MP
Manoussos PerrosFounder
MG
Michael GutchExecutive
DA
David AltaracExecutive
EK
Elizabeth KeileyExecutive
RT
Ruben TommasiExecutive
JM
John MuellerNamed on SEC filing
DM
David MeekNamed on SEC filing
DH
David HastingsNamed on SEC filing
HM
Howard MayerNamed on SEC filing
HP
Heather PrestonNamed on SEC filing
Board
HB
Investors · 1
Reported raises · per SEC filings
Form D private placements$25M disclosed across 1 round · 2020
▶$25MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
▶$25MraisedSep 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GutchExecutive Officer
- John MuellerExecutive Officer
- Heather BehannaDirector
- David AltaracExecutive Officer
- David MeekDirector
- David HastingsDirector
- Elizabeth KeileyExecutive Officer
- Ruben TommasiExecutive Officer
- Howard MayerDirector
- Heather PrestonDirector
- Manoussos PerrosExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- Sales commissions
- $1.3M
- Placement agents
- A.G.P. / Alliance Global Partner, Cantor Fitzgerald & Co.
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Entasis Therapeutics Holdings?
- Entasis Therapeutics Holdings was founded by Manoussos Perros in 2018.
- Who are Entasis Therapeutics Holdings's investors?
- Entasis Therapeutics Holdings's investors include SR One Capital Management.
- How much funding has Entasis Therapeutics Holdings raised?
- Entasis Therapeutics Holdings has disclosed $25M raised across 1 round.
- Where is Entasis Therapeutics Holdings headquartered?
- Entasis Therapeutics Holdings is headquartered in Waltham, US.